De Novo Linear Phosphorylation Site Motifs for BCR-ABL Kinase Revealed by Phospho-Proteomics in Yeast

被引:1
|
作者
Smolnig, Martin [1 ,2 ]
Fasching, Sandra [1 ]
Stelzl, Ulrich [1 ,3 ,4 ]
机构
[1] Karl Franzens Univ Graz, Inst Pharmaceut Sci, Pharmaceut Chem, A-8010 Graz, Austria
[2] Univ Witten Herdecke UW H, Chair Biochem & Mol Med, Ctr Biomed Educ & Res ZBAF, D-58453 Witten, Germany
[3] BioTechMed Graz, A-8010 Graz, Austria
[4] Karl Franzens Univ Graz, Field Excellence Biohlth, A-8010 Graz, Austria
基金
奥地利科学基金会;
关键词
oncogenic kinase signaling; protein tyrosine phosphorylation; Abelson murine leukemia viral oncogene homologue 1; kinase set enrichment analysis; linear sequence motif; TYROSINE KINASE; V-ABL; LEUKEMIA; P210; SPECIFICITY; MECHANISMS; DISCOVERY; NETWORKS; PLATFORM; P190;
D O I
10.1021/acs.jproteome.2c00795
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
BCR-ABL is the oncogenic fusion product of tyrosine kinase ABL1 and a highly frequent driver of acute lymphocytic leukemia (ALL) and chronic myeloid leukemia (CML). The kinase activity of BCR-ABL is strongly elevated; however, changes of substrate specificity in comparison to wild-type ABL1 kinase are less well characterized. Here, we heterologously expressed full-length BCR-ABL kinases in yeast. We exploited the proteome of living yeast as an in vivo phospho-tyrosine substrate for assaying human kinase specificity. Phospho-proteomic analysis of ABL1 and BCR-ABL isoforms p190 and p210 yielded a high-confidence data set of 1127 phospho-tyrosine sites on 821 yeast proteins. We used this data set to generate linear phosphorylation site motifs for ABL1 and the oncogenic ABL1 fusion proteins. The oncogenic kinases yielded a substantially different linear motif when compared to ABL1. Kinase set enrichment analysis with human pY-sites that have high linear motif scores well-recalled BCR-ABL driven cancer cell lines from human phospho-proteome data sets.
引用
收藏
页码:1790 / 1799
页数:10
相关论文
共 7 条
  • [1] Occurrence of de novo ABL kinase domain mutations in primary bone marrow cells after BCR-ABL gene transfer and imatinib mesylate selection
    Flamant, S
    Turhan, AG
    LEUKEMIA, 2005, 19 (07) : 1265 - 1267
  • [2] Occurrence of de novo ABL kinase domain mutations in primary bone marrow cells after BCR-ABL gene transfer and Imatinib mesylate selection
    S Flamant
    A G Turhan
    Leukemia, 2005, 19 : 1265 - 1267
  • [3] Phospho-proteomics: Evaluation of the use of enzymatic de-phosphorylation and differential mass spectrometric peptide mass mapping for site specific phosphorylation assignment in proteins separated by gel electrophoresis
    Larsen, MR
    Sorensen, GL
    Fey, SJ
    Larsen, PM
    Roepstorff, P
    PROTEOMICS, 2001, 1 (02) : 223 - 238
  • [4] DE NOVO DESIGN AND VIRTUAL SCREENING OF POTENTIAL Bcr-Abl TYROSINE KINASE INHIBITORS USING DEEP LEARNING AND MOLECULAR MODELING TECHNOLOGIES
    Andrianov, Alexander M.
    Furs, Konstantin, V
    Karpenko, Anna D.
    Vaitko, Timofey D.
    Tuzikov, Alexander V.
    DOKLADY NATSIONALNOI AKADEMII NAUK BELARUSI, 2024, 68 (03): : 196 - 206
  • [5] De novo ABL kinase domain mutations in murine bone marrow cells retrovirally transduced with wild-type p210 BCR-ABL and amplified in culture with imatinib mesylate.
    Flamant, S
    Guillier, M
    Bonnet, ML
    Lecouedic, JP
    Vainchenker, W
    Turhan, AG
    BLOOD, 2004, 104 (11) : 549A - 549A
  • [6] Different outgrowth kinetics of clones with BCR-ABL kinase domain mutations in de novo versus relapsed Philadelphia-positive all imply an additional role of non-mutational resistance mechanisms
    Pfeifer, H.
    Wassmann, B.
    Wystub, S.
    Lange, T.
    Hochhaus, A.
    Hoelzer, D.
    Ottmann, O. G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 135 - 135
  • [7] Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)
    Pfeifer, Heike
    Wassmann, Barbara
    Pavlova, Anna
    Wunderle, Lydia
    Oldenburg, Johannes
    Binckebanck, Anja
    Lange, Thoralf
    Hochhaus, Andreas
    Wystub, Silvia
    Brueck, Patrick
    Hoelzer, Dieter
    Ottmann, Oliver G.
    BLOOD, 2007, 110 (02) : 727 - 734